glp 1 migraine Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain Activation of microglial GLP-1R in
Description
A 10 percent reduction in body weight is associated with a roughly 26 percent reduction in AHI (Peppard et al., JAMA , 2000)
Methods We identified genetic proxies of the effect of GLP-1R, GIPR, and GCGR by combining Mendelian randomization (MR), Bayesian colocalization, and linkage disequilibrium (LD) analyses
In the landmark 68-week STEP-1 trial, adults with overweight or obesity who reached the 2.4 mg maintenance dose lost roughly 15% of their body weight on average a magnitude that had previously belonged to bariatric surgery, not an injection
Liquid sugar is absorbed quickly and doesnt create fullness, which works against appetite control
Most patients notice reduced appetite within the first week and measurable weight loss within 2-4 weeks of starting GLP-1 therapy
